Biocept Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BIOC Nasdaq 2834 https://biocept.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biocept Inc

Biocept's Liquid Biopsy CTC Testing for Breast Cancer to Be Featured in Poster Presentation at the 2019 San Antonio Breast Cancer Symposium® - Dec 3rd, 2019 1:05 pm
Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cancer - Nov 21st, 2019 1:05 pm
Biocept Reports Third Quarter 2019 Financial Results - Nov 13th, 2019 9:05 pm
Biocept Announces CE IVD Marks and Availability of its CEE-Sure® Blood Collection Tube and Sample Collection Shipping Kit in Europe - Nov 7th, 2019 1:05 pm
Biocept to Release Third Quarter 2019 Financial Results and Host Investor Conference Call on November 13, 2019 - Nov 6th, 2019 1:05 pm
Biocept's Target Selector™ Tests and Kits to Be Featured in Six Poster Presentations at the 2019 Association for Molecular Pathology Annual Meeting - Nov 4th, 2019 1:05 pm
Why Biocept, Inc.'s (NASDAQ:BIOC) CEO Pay Matters To You - Oct 14th, 2019 2:05 pm
Biocept's Target Selector™ ctDNA Platform Demonstrates Single Copy Detection for EGFR, BRAF, and KRAS Mutations; Study Results Published in Peer-Reviewed Journal, PLOS ONE - Oct 7th, 2019 12:05 pm
Biocept Announces Issuance of South Korean Patent Covering its Target Selector™ Oncogene Mutation Enrichment and Detection Platform - Oct 3rd, 2019 12:05 pm
Biocept to Present at Two Investment Conferences in September - Sep 3rd, 2019 12:05 pm
High Sensitivity of Biocept's Target Selector™ Platform Using CEE-Sure™ Blood Collection Tubes to Be Featured in Poster Presentation at the 2019 IASLC World Conference on Lung Cancer - Aug 22nd, 2019 12:05 pm
Biocept Receives Three Additional Patents Covering its Antibody and Microchannel Technology and Enhanced Detection of Cancer Cells - Aug 13th, 2019 12:05 pm
Biocept Reports Second Quarter 2019 Financial Results - Aug 12th, 2019 8:05 pm
Biocept, Inc. to Host Earnings Call - Aug 12th, 2019 6:30 pm
Biocept to Release Second Quarter 2019 Financial Results and Host Investor Conference Call on August 12, 2019 - Aug 5th, 2019 12:05 pm
Biocept Announces Laboratory Services Provider Agreement with BeaconLBS® - Jul 22nd, 2019 12:05 pm
Does Biocept, Inc. (NASDAQ:BIOC) Have A High Beta? - Jul 16th, 2019 5:31 pm
Biocept Announces Commercial Launch of Target Selector™ NGS Breast Panel, the Company's Second Multi-Gene Tumor-Specific Panel - Jun 18th, 2019 12:05 pm
Biocept to Present at the 9th Annual LD Micro Invitational Conference on June 4 - Jun 3rd, 2019 12:05 pm
Biocept Awarded Patent in China for its Circulating Tumor Cell Platform Expanding Intellectual Property Estate to 33 Issued Patents Globally - May 28th, 2019 12:05 pm